loving care are not just restricted to treating a particular symptom, disease or patient but rather to holistically improving the overall health quotient of our patients, we have consolidated all our clinical assets in oncology into an independent integrated specialty practice under Apollo Cancer institutes. These institutes will function from a common platform based on standard protocols which will ensure uniform quality of care for patients while elevating the track record and knowledge bank for specialists across the network. We are also now well poised to become the first provider of the revolutionary Proton Beam Therapy treatment for cancer cure in India. The machine is with us and we will launch the centre in 2018. This will serve patients in the UK, Europe, the Middle East, Australia, Singapore, Malaysia, and other countries in South and South East Asia, as it will be the only one of its kind in this region. This initiative exemplifies our Mission and our commitment to provide the best possible healthcare to put people on the road to recovery.
I would like to share with you our joy and pride in Apollo Hospitals, Greams Lane, Chennai receiving the #1 Top Super Specialty Hospital in India ranking in India, followed by Apollo Indraprastha, New Delhi, in the #2 spot. Our hospitals were also ranked #1 Multi Specialty Hospitals in Chennai, Hyderabad, and Bangalore, I am also pleased to state that Apollo Hospitals, Greams Lane, Chennai, won the best Multi-Specialty Hospital Megapolis in the country award at the ICICI Lombard & CNBC TV18 India Healthcare Awards 2016.
We launched our 480-bed hospital in Mumbai in November 2016. it is one of the most advanced Multi-Specialty Tertiary Care Hospitals in the region and effectively represents the final leg of our current expansion plan which has resulted in an increase of capacity by 30% with the addition of -2,500 beds over the last 3 years. We are pleased to share that we have now crossed the milestone of 10,000 beds capacity across our pan India network. Our focus is to have a dominant market presence in all these locations over the next 2 years by delivering superior clinical outcomes and service standards.
Growth in our Healthcare Services has been led by strong momentum at several of the newer facilities as new hospitals have reported 51% growth in revenues on a year on year basis driven by strong growth in volumes.
The international Finance Corporation, Washington DC, along with its associates acquired a 29% stake in Apollo Health and Lifestyle Limited (AHLL). AHLL will expand its network of clinics, cradles and diagnostics centers all across India. it has recently introduced clinics specializing in stroke and elder care, setting new path breaking trends in the retail health landscape.
The Standalone Pharmacy business revenues grew by 24% with EBITDA growth at 53%. Last year we added 285 stores and closed 55 stores for a net addition of 230 stores. The total number of stores in our network is now 2,556 on a pan India basis.
Despite some external setbacks, the group had another good financial year with consolidated annual revenues growing 17% to Rs. 73 billion and consolidated net profits of Rs. 2 billion. Consolidated EPS for the year stood at Rs. 15.9. We are happy to declare a dividend of Rs. 6 per share for the fiscal year 2017.
Our journey is not yet over. We have a long way to go to achieve our vision of bringing quality health care to India’s masses. But i am confident that we have made a good start and our fundamentals are robust enough to deliver that goal.
I thank you all for the trust you have reposed in our hospitals and thank each and every stakeholder for their continued support in our journey.
I wish you and your families all the very best of health and wellness.
With warm personal regards,
Dr. Prathap C Reddy
Executive Chairman Apollo Hospitals Group